| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $194,241 ) |
| | 2024 | 2024 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 000 | 4 | NIH | 8/27/2024 | $194,241 |
|
| Issue Date FY: 2023 ( Subtotal = $302,725 ) |
| | 2023 | 2023 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 001 | 3 | NIH | 8/30/2023 | $302,725 |
| | 2023 | 2022 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 000 | 2 | NIH | 10/12/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $306,818 ) |
| | 2022 | 2022 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 001 | 2 | NIH | 8/30/2022 | $306,818 |
| | 2022 | 2020 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 000 | 1 | NIH | 7/28/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 000 | 1 | NIH | 8/13/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $317,425 ) |
| | 2020 | 2020 | THE FRANCIS CRICK INSTITUTE LIMITED | 1 MIDLAND ROAD | LONDON | | NW1 1AT | | GBR | U01CA247439 | Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas | 000 | 1 | NIH | 9/4/2020 | $317,425 |
|
|
